AbCellera Biologics (NASDAQ:ABCL) Price Target Cut to $10.00 by Analysts at Truist Financial
AbCellera Biologics (NASDAQ:ABCL – Free Report) had its price target trimmed by Truist Financial from $28.00 to $10.00 in a report released on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. Several other analysts also recently issued reports on the stock. Benchmark reaffirmed a “hold” rating on shares of AbCellera […]
AbCellera Biologics (NASDAQ:ABCL – Free Report) had its price target trimmed by Truist Financial from $28.00 to $10.00 in a report released on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. Several other analysts also recently issued reports on the stock. Benchmark reaffirmed a “hold” rating on shares of AbCellera […]
